These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6093810

  • 1. Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor Sepharose chromatography.
    Umekawa H, Tanaka T, Kimura Y, Hidaka H.
    Biochem Pharmacol; 1984 Nov 01; 33(21):3339-44. PubMed ID: 6093810
    [Abstract] [Full Text] [Related]

  • 2. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.
    LeBon TR, Kasuya J, Paxton RJ, Belfrage P, Hockman S, Manganiello VC, Fujita Yamaguchi Y.
    Endocrinology; 1992 Jun 01; 130(6):3265-74. PubMed ID: 1317779
    [Abstract] [Full Text] [Related]

  • 3. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
    Hidaka H, Asano T.
    Biochim Biophys Acta; 1976 Apr 08; 429(2):485-97. PubMed ID: 177073
    [Abstract] [Full Text] [Related]

  • 4. Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand.
    Degerman E, Belfrage P, Newman AH, Rice KC, Manganiello VC.
    J Biol Chem; 1987 Apr 25; 262(12):5797-807. PubMed ID: 3032944
    [Abstract] [Full Text] [Related]

  • 5. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
    Hidaka H, Hayashi H, Kohri H, Kimura Y, Hosokawa T, Igawa T, Saitoh Y.
    J Pharmacol Exp Ther; 1979 Oct 25; 211(1):26-30. PubMed ID: 226672
    [No Abstract] [Full Text] [Related]

  • 6. Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity.
    Sudo T, Tachibana K, Toga K, Tochizawa S, Inoue Y, Kimura Y, Hidaka H.
    Biochem Pharmacol; 2000 Feb 15; 59(4):347-56. PubMed ID: 10644042
    [Abstract] [Full Text] [Related]

  • 7. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
    Alvarez R, Banerjee GL, Bruno JJ, Jones GL, Littschwager K, Strosberg AM, Venuti MC.
    Mol Pharmacol; 1986 Jun 15; 29(6):554-60. PubMed ID: 3012320
    [Abstract] [Full Text] [Related]

  • 8. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
    Hidaka H, Asano T.
    J Biol Chem; 1976 Dec 10; 251(23):7508-16. PubMed ID: 187590
    [Abstract] [Full Text] [Related]

  • 9. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from the cytosol of human platelets.
    Grant PG, Mannarino AF, Colman RW.
    Thromb Res; 1990 Jul 01; 59(1):105-19. PubMed ID: 2169075
    [Abstract] [Full Text] [Related]

  • 10. Inhibitors of cyclic AMP phosphodiesterase. 1. Analogues of cilostamide and anagrelide.
    Jones GH, Venuti MC, Alvarez R, Bruno JJ, Berks AH, Prince A.
    J Med Chem; 1987 Feb 01; 30(2):295-303. PubMed ID: 3027338
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
    Kahn NN, Sinha AK.
    Biochim Biophys Acta; 1989 Aug 21; 984(1):113-8. PubMed ID: 2548620
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate.
    Beretz A, Briançon-Scheid F, Stierlé A, Corre G, Anton R, Cazenave JP.
    Biochem Pharmacol; 1986 Jan 15; 35(2):257-62. PubMed ID: 3002388
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.
    Grant PG, Colman RW.
    Biochemistry; 1984 Apr 10; 23(8):1801-7. PubMed ID: 6326810
    [Abstract] [Full Text] [Related]

  • 15. Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscle.
    Rascón A, Lindgren S, Stavenow L, Belfrage P, Andersson KE, Manganiello VC, Degerman E.
    Biochim Biophys Acta; 1992 Mar 16; 1134(2):149-56. PubMed ID: 1313303
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro.
    Ruppert D, Weithmann KU.
    Life Sci; 1982 Nov 08; 31(19):2037-43. PubMed ID: 6294426
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tissue and substrate specificity of inhibition by alkoxy-aryl-lactams of platelet and arterial smooth muscle cyclic nucleotide phosphodiesterases relationship to pharmacological activity.
    Lugnier C, Stierlé A, Beretz A, Schoeffter P, Lebec A, Wermuth CG, Cazenave JP, Stoclet JC.
    Biochem Biophys Res Commun; 1983 Jun 29; 113(3):954-9. PubMed ID: 6307307
    [Abstract] [Full Text] [Related]

  • 20. Purification of a cyclic nucleotide phosphodiesterase from bovine brain using blue dextran-Sepharose chromatography.
    Morrill ME, Thompson ST, Stellwagen E.
    J Biol Chem; 1979 Jun 10; 254(11):4371-4. PubMed ID: 220243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.